Product Images Ketorolac Tromethamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Ketorolac Tromethamine NDC 0404-9952 by Henry Schein, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Formula1.jpg - Formula1

Formula1.jpg - Formula1

Image1.jpg - Image1

Image1.jpg - Image1

This text appears to be a chart or table displaying various pharmacokinetic parameters for a medication administered via oral, intramuscular, or intravenous bolus routes. The table includes measurements such as bioavailability, time to peak plasma concentration, peak and average plasma concentrations, volume of distribution, and the percentage of the dose metabolized or excreted in urine or feces. The data is derived from pharmacokinetic studies in normal volunteers for each route of administration.*

Image2.jpg - Image2

Image2.jpg - Image2

Image3.jpg - Image3

Image3.jpg - Image3

This is a list of possible side effects related to gastrointestinal (Gl) symptoms such as abdominal pain, constipation/diarrhea, dyspepsia, flatulence, Gl fullness, Gl ulcers (gastric/duodenal), gross bleeding/perforation, heartburn, nausea, stomatitis, and vomiting. Other potential side effects include abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating. The incidence of these side effects, which may occur as a result of medication or treatment, is greater than 10%.*

Image4.jpg - Image4

Image4.jpg - Image4

This appears to be a chart showing the percentage of adult patients with and without a history of pub (potentially peptic ulcer bleeding) who received different doses of ketorolac tromethamine injection. The chart is divided into age groups and shows the percentage of patients who received a total daily dose of less than 60mg, between 60mg to 90mg, between 90mg to 120mg, and over 120mg.*

Image5.jpg - Image5

Image5.jpg - Image5

This is the NDC number and package factor for Ketorolac Tromethamine injection USP, which is available in 15mg/mL, 30mg/mL, and 60mg/2mL single-dose vials. Each carton contains 25 vials. It is for intramuscular use only.*

Label1.jpg - Label1

Label1.jpg - Label1

Ketorolac Tromethamine is a solution for intramuscular or intravenous use only. It is provided in a single-dose vial and should be kept away from children. The injection should be retained in the bag until the time of use, and unused portions should be discarded. The manufacturer information includes Mir: AlmaJect, and it is RX only. The packaging is done by Henry Schein, Inc, and the product is available in the temperature range of 21-27°C. The GTIN number is not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.